Philips : Home oxygen measurement solution for sleep and ventilation launched at ERS 2011

September 29, 2011 - Philips’ latest launch reinforces its commitment to providing monitoring solutions that support patient care at home - Home oxygen measurement solution for sleep and ventilation launched at ERS 2011 - Royal Philips Electronics (NYSE: PHG, AEX: PHI) has launched the new Oximetry Module, a home oxygen measurement device designed to monitor people diagnosed with respiratory disorders such as sleep apnea and chronic obstructive pulmonary disease (COPD) and to record their blood oxygen level by means of a single finger probe.

The Oximetry Module, which was launched during the 2011 Congress of the European Respiratory Society (ERS) in Amsterdam, is designed to help physicians to better determine whether complex respiratory events are present during a person’s period of sleep at home.

“Non-invasive ventilation (NIV) (or home ventilation) has been demonstrated to be effective treatment in some forms of respiratory failure. When starting NIV, it seems desirable to verify whether this particular form of treatment is effective and has no untoward effects. Greater insight, provided by simple cost effective monitoring tools like oximetry and other signals obtained from non-invasive positive pressure ventilation (NPPV) devices; help identify issues early in the patient’s therapy. This subsequently improves their long term outcomes and quality of life... Philips' Press Release -

Philips strengthens home healthcare portfolio with acquisition of main business of medSage Technologies

January 6, 2011 - Royal Philips Electronics (AEX: PHI, NYSE: PHG) announced that it has acquired substantially all of the assets of medSage Technologies LLC, a leading provider of patient interaction and management applications (“medSage Technologies”). The acquisition will allow Philips to offer a web-based solution that enables home care providers to manage ongoing compliance and replenishment services for individuals under treatment for obstructive sleep apnea (OSA), diabetes, respiratory and other conditions. The acquired business will become part of the Sleep business within Philips Home Healthcare Solutions.

“We believe the need to manage chronic diseases by an aging population, coupled with health economics, will continue to drive a greater need for healthcare delivery at home,” said Steve Rusckowski, CEO of Philips Healthcare. “This acquisition is fully aligned to our strategy of providing home care providers with new opportunities to enhance their service offerings with an effective and cost-efficient application.” Philips' Press Release -

Nonin Medical Recognized as a Supplier to the Award-Winning Philips Respironics Alice© PDx™ System

June 10, 2010 - Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, announced that it is a named supplier for a 2010 Medical Design Excellence Award winning product—the Philips Respironics Alice© PDx™ Diagnostic System.

The Alice© PDx™ portable diagnostic recording device is intended for Obstructive Sleep Apnea screening, follow-up and diagnostic assessment of cardio-respiratory sleep disorders. It enables patients to be tested outside of the lab without compromising study results and helps clinicians avoid the costs associated with retesting.


Incorporating Nonin Medical’s proven PureSAT® pulse oximetry (SpO2) technology, the Alice PDx system uses Nonin’s OEM III SpO2 module. An easy-to-integrate oximetry solution, the OEM III module’s compact design, power efficiency and expanded output capabilities provides manufacturers with dependable, accurate performance and maximum flexibility... Nonin Medical's Press Release -

Philips Respironics : Prestigious GSMA Award

March 3, 2010 - Philips Respironics and Cinterion Wireless Modules Win Prestigious GSMA Award for Best Embedded Mobile End-to-End Service – Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Cinterion Wireless Modules, the global leader in cellular machine-to-machine (M2M) communication modules, announced that the Philips Respironics System One sleep therapy solution won the prestigious Best Embedded End-to-End Service Award, part of the GSMA’s Embedded Mobile Competition. The M2M solution integrates one of Cinterion’s award-winning Evolution Platform modules and, for the first time, marries mobility and reliable two-way wireless communications with significant advancements in sleep apnea therapy to help millions of patients and their healthcare providers who must meet rigorous new reporting standards. The device currently operates on the nPhase AT&T network in the U.S. and will roll out in markets around the world over the coming year.

Sleep apnea is a potentially life threatening condition that occurs when a person repeatedly stops breathing during sleep. System One provides treatment by delivering a specific flow of pressurized air through a mask to keep the airway open. The new solution integrates Cinterion’s award-winning TC65i module to enable two-way, anywhere wireless communication between the patient’s device and doctor. The Cinterion module sends sophisticated patient breathing data from the device to a secure EncoreAnywhere™ Web-based platform. Physicians log on to EncoreAnywhere to obtain timely, detailed breathing reports and respond with prescription air pressure changes sent instantly over-the-air to the device providing immediate patient relief. Cinterion’s TC65i module provides on-board memory to store reports that detail every breath a patient takes for up to five days... Philips Respironics' Press Release - Cinterion Wireless Modules' Press Release -